- Home
- ILMN vs CHRW Comparison
ILMN vs CHRW Comparison
Compare ILMN & CHRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- CHRW
- Stock Information
- Founded
- ILMN 1998
- CHRW 1905
- Country
- ILMN United States
- CHRW United States
- Employees
- ILMN N/A
- CHRW N/A
- Industry
- ILMN Medical Specialities
- CHRW Oil Refining/Marketing
- Sector
- ILMN Health Care
- CHRW Consumer Discretionary
- Exchange
- ILMN Nasdaq
- CHRW Nasdaq
- Market Cap
- ILMN 15.3B
- CHRW 14.8B
- IPO Year
- ILMN 2000
- CHRW 1997
- Fundamental
- Price
- ILMN $121.18
- CHRW $149.33
- Analyst Decision
- ILMN Hold
- CHRW Buy
- Analyst Count
- ILMN 15
- CHRW 22
- Target Price
- ILMN $114.93
- CHRW $137.86
- AVG Volume (30 Days)
- ILMN 2.1M
- CHRW 1.8M
- Earning Date
- ILMN 10-30-2025
- CHRW 10-29-2025
- Dividend Yield
- ILMN N/A
- CHRW 1.66%
- EPS Growth
- ILMN N/A
- CHRW 70.68
- EPS
- ILMN 4.46
- CHRW 4.94
- Revenue
- ILMN $4,288,000,000.00
- CHRW $16,504,785,000.00
- Revenue This Year
- ILMN N/A
- CHRW N/A
- Revenue Next Year
- ILMN $2.22
- CHRW $3.07
- P/E Ratio
- ILMN $27.33
- CHRW $30.28
- Revenue Growth
- ILMN N/A
- CHRW N/A
- 52 Week Low
- ILMN $68.70
- CHRW $84.68
- 52 Week High
- ILMN $155.99
- CHRW $158.70
- Technical
- Relative Strength Index (RSI)
- ILMN 66.82
- CHRW 67.43
- Support Level
- ILMN $118.50
- CHRW $150.32
- Resistance Level
- ILMN $126.00
- CHRW $154.68
- Average True Range (ATR)
- ILMN 5.02
- CHRW 3.73
- MACD
- ILMN 2.48
- CHRW 1.97
- Stochastic Oscillator
- ILMN 84.61
- CHRW 71.89
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.